Valuation: AVRA Medical Robotics, Inc.

Market Cap 72Cr 63Cr 58Cr 54Cr 100.99Cr 6.9TCr 102.21Cr 694.47Cr 271.76Cr 3.38TCr 268.95Cr 263.16Cr 12TCr P/E 2026 *
-59.7x
P/E 2027 * -59.7x
Enterprise Value 72Cr 63Cr 58Cr 54Cr 100.99Cr 6.9TCr 102.21Cr 694.47Cr 271.76Cr 3.38TCr 268.95Cr 263.16Cr 12TCr EV / Sales 2026 *
12.1x
EV / Sales 2027 * 9.53x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 5.12Cr
-0.18%-3.16%+0.43%+14.89% 4.85TCr
+1.61%-0.91%+377.07%+584.68% 3.9TCr
+2.61%+3.96%+9.16%+61.36% 3.54TCr
-1.12%-2.99%+26.84%-11.67% 3.37TCr
-0.58%-0.69%-0.56%+30.30% 2.66TCr
+1.37%-3.90% - - 1.68TCr
+0.71%-0.84%+72.13%+116.76% 1.52TCr
-2.03%+0.96%+13.12%+14.01% 1.39TCr
+0.26%-0.80%+19.33%-32.25% 1.28TCr
Average -0.09%-0.93%+64.69%+97.26% 2.69TCr
Weighted average by Cap. +0.42%-1.00%+77.57%+122.90%

Financials

2026 *2027 *
Net sales 5.94Cr 5.21Cr 4.82Cr 4.44Cr 8.37Cr 572.07Cr 8.47Cr 58Cr 23Cr 280.36Cr 22Cr 22Cr 968.02Cr 7.52Cr 6.59Cr 6.11Cr 5.62Cr 11Cr 724.23Cr 11Cr 73Cr 29Cr 354.93Cr 28Cr 28Cr 1.23TCr
Net income -1.2Cr -1.05Cr -97.46L -89.7L -1.69Cr -115.57Cr -1.71Cr -12Cr -4.55Cr -57Cr -4.5Cr -4.41Cr -195.56Cr -1.4Cr -1.23Cr -1.14Cr -1.05Cr -1.97Cr -134.83Cr -2Cr -14Cr -5.31Cr -66Cr -5.26Cr -5.14Cr -228.15Cr
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-